Recent Company News

• 06:18 PM ET Nov 19, 2025
  

  Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights

• 02:10 PM ET Nov 19, 2025
  

  $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-CMA, HFWA, BRNS, and FITB

• 01:55 PM ET Nov 12, 2025
  

  Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights

• 07:35 AM ET Nov 07, 2025
  

  Barinthus Biotherapeutics reports Q3 EPS ($0.36) vs FactSet ($0.40) [2 est, ($0.45)-(0.34)] ($1.19, 0.00)

• 11:01 AM ET Oct 24, 2025
  

  ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics

• 11:58 PM ET Oct 16, 2025
  

  SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders

• 12:15 PM ET Oct 07, 2025
  

  SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders

• 11:14 AM ET Oct 06, 2025
  

  StreetAccount M&A Summary: Week of 29-Sep

• 08:07 AM ET Sep 30, 2025
  

  Barinthus Biotherapeutics to combine with Clywedog Therapeutics in all-stock transaction ($1.48, 0.00)

• 08:11 AM ET Aug 07, 2025
  

  Barinthus Biotherapeutics reports Q2 EPS ($0.52) vs FactSet ($0.33) [2 est, ($0.37)-(0.29)] ($1.31, 0.00)